Portuguese-language VISs
Out-of-date

The translations for some VISs on our website are from previously published English-language versions that have since been updated. Unfortunately, IAC is not always able to obtain translations as updates are issued. Please ensure that your patients receive information consistent with the current English-language version of the following VISs.

You are encouraged to distribute the up-to-date English-language VIS at the same time as the translation.

Chickenpox VIS [12/16/98]

|

Up-to-date English-language [3/13/08]

This translation does not contain the following CDC updates:

• Section 1: The answer has been rewritten by CDC.
• Section 2: There are now 2 doses; the first dose is 12-15 months and the second dose is 4-6 years.
• CDC added information on MMRV.
• The URL for Vaccine Adverse Event Reporting System (VAERS) has changed to www.vaers.hhs.gov.
• The URL for the National Vaccine Injury Compensation Programs has changed to www.hrsa.gov/vaccincompensation.

DTaP VIS [7/30/01]

|

Up-to-date English-language [5/17/07]

These translations do not contain the following CDC updates:

• These translations do not contain the following CDC updates
• The main change is in Section 4, which now mentions Tdap.
• The NVICP and VAERS web addresses have also been updated
• The mortality rate for tetanus in Section 1 changed from 1 out of 10, to 2 out of 10 cases.
• The date changed to 5/17/07.

Hepatitis A VIS [8/25/98]

|

Up-to-date English-language [3/21/06]

This translation does not contain the following CDC updates:

• CDC changed the indication to 1 year or older and has recommended routine use for children.
• Section 2: Added persons who work with primates or in research labs to indications (routine vaccination).
• Added bullet for "persons who live in communities that have prolonged outbreaks of hepatitis A."
• Divided the section into "Who" and "When" parts.
• Removed southern Europe from list of regions with high rates of hepatitis A.
• Section 3: Added bullet about allergy to vaccine component.
• Changed wording, particularly the statement on pregnancy, and made list into bullets.
• Minor changes to part 4, 5, and 6 to be consistent with other recent VISs.
• Removed the section on immune globulin.

Hepatitis B VIS

|

Up-to-date English-language [7/18/07]

These translations do not contain the following CDC updates:

• On July 18, the CDC posted an interim VIS for hepatitis B. There are minor changes throughout, but the main purpose of the update is to emphasize the birth dose for all children.
• A final version will be developed.

Influenza - Inactivated VIS

|

English-language [7/24/08]

This translation does not contain the following CDC updates:

• For 2008-09, the inactivated influenza vaccine VIS states in section 3 that all children from 6 months through 18 years of age should get inactivated influenza vaccine.

Influenza - Live intranasal VIS

|

Up-to-date English-language [7/24/08]

These translations do not contain the following CDC update:

• For 2008-09, the live, intranasal influenza vaccine (LAIV) VIS states in section 3 that LAIV is approved for people from 2 through 49 years of age, who are not pregnant and do not have certain health conditions.
• Changed to "for healthy people from 2 through 49 years of age." Dated 10/4/07.
• CDC updated the VIS for the 2007-08 season. Only influenza vaccines and the VIS for the 2007-08 season should be used. All influenza vaccines from the previous season have expired.

MMR VIS

|

Up-to-date English-language [3/13/08]

• Information was added about MMRV vaccine, tied to the March 14 MMWR, regarding increased risk of certain adverse events, including febrile seizures, with MMRV when compared with MMR and varicella vaccines given separately. Aside from two boxes containing information about MMRV, both VISs are identical to the previous editions.
• The new VISs should be used when MMRV is given; but the existing stocks of the individual MMR and varicella VISs may be used when the vaccines are given separately.

Pneumococcal - PCV7 VIS

|

Up-to-date English-language [12/9/08]

• The CDC posted an updated interim PCV VIS on 12/9/08. The main reason is to incorporate recent changes in recommendations for 2-4 year olds, but there are other changes throughout as well. There are no changes in contraindications or adverse events, but to prevent parents from getting confused about the differences in indications (especially when the vaccine is administered to 2-4 year olds) it would be best for providers to start using the new version right away. Existing stocks CAN still be used temporarily if immediately switching to the new version is a problem.

This page was updated on December 11, 2008